DSIP / dsip ,
McDonald's CEO on GLP-1 Impact: No Material Business Effect Yet, Company Adapts Menu McDonald's CEO Chris Kempczinski, during a February 11 earnings call reported by Yahoo Finance, addressed the impact of rising GLP-1 medication usage on the fast-food industry
However, if you are looking for a top-rated, inexpensive, and flexible app-based wellness program with decades of success, Im happy to recommend WeightWatchers
Existing epidemiologic and mechanistic data support a potential role for GLP-1 receptor agonists in dementia risk reduction, particularly in metabolically vulnerable populations [14,15]
Scientists use BPC-157 peptide to investigate fundamental cellular and tissue-level signaling mechanisms
Tirzepatide has a shorter half-life but carries similar guidance